Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biomol Struct Dyn ; 37(11): 2960-2969, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30058445

RESUMO

In this work, we combined molecular modeling, computational docking and in vitro analysis to explore the antileishmanial effect of some resveratrol analogs (ResAn), focusing on their pro-oxidant effect. The molecular target was the trypanothione reductase of Leishmania braziliensis (LbTryR), an essential component of the antioxidant defenses in trypanosomatid parasites. Three-dimensional structures of LbTryR were modeled and molecular docking studies of ResAn1-5 compounds showed the following affinity: ResAn1 > ResAn2 > ResAn4 > ResAn5 > ResAn3. Positive correlation was observed between these compounds' affinity to the LbTryR and the IC50 values against Leishmania sp (ResAn1 < ResAn2 < ResAn4), which allows for TryR being considered an important target for them. As the compound ResAn1 showed the best antileishmanial activity, and docking studies showed its high affinity for NADP binding site (NS) of TryR, plus having been able to induce ROS production in L. braziliensis promastigotes treated, ResAn1 probably occupies NS interfering in the electron transfer processes responsible for the catalytic reaction. The in silico prediction of ADMET properties suggests that ResAn1 may be a promising drug candidate with properties to cross biological membranes and high gastrointestinal absorption, not violating Lipinski's rules. Ultimately, the antileishmanial effect of ResAn can be associated with a pro-oxidant effect which, in turn, can be exploited as an antimicrobial agent. Communicated by Ramaswamy H. Sarma.


Assuntos
Antiprotozoários/farmacologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Leishmania braziliensis/efeitos dos fármacos , Leishmania braziliensis/enzimologia , Leishmaniose/tratamento farmacológico , NADH NADPH Oxirredutases/metabolismo , Resveratrol/química , Animais , Antioxidantes/química , Antioxidantes/farmacologia , Antiprotozoários/química , Sítios de Ligação , Leishmaniose/parasitologia , Macrófagos/efeitos dos fármacos , Macrófagos/enzimologia , Macrófagos/parasitologia , Camundongos , Camundongos Endogâmicos BALB C , Modelos Moleculares , Simulação de Acoplamento Molecular , Estrutura Molecular , NADH NADPH Oxirredutases/química , Conformação Proteica , Proteínas de Protozoários/química , Proteínas de Protozoários/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Resveratrol/farmacologia , Relação Estrutura-Atividade
2.
Chem Biodivers ; 15(12): e1800398, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30276965

RESUMO

In this study, we evaluated the in vitro and in vivo schistosomicidal activities of chalcones against Schistosoma mansoni worms. In vitro assays revealed that chalcones 1 and 3 were the most active compounds, without affecting significantly mammalian cells. Confocal laser scanning microscopy and scanning electron microscopy studies revealed reduction on the numbers of tubercles and morphological alterations in the tegument of S. mansoni worms after in vitro incubation with chalcones 1 and 3. In a mouse model of schistosomiasis, the oral treatment (400 mg/kg) with chalcone 1 or 3 significantly caused a total worm burden reduction in mice. Chalcone 1 showed significant inhibition of the S. mansoni ATP diphosphohydrolase activity, which was corroborated by molecular docking studies. The results suggested that chalcones could be explored as lead compounds with antischistosomal properties.


Assuntos
Anti-Helmínticos/química , Chalconas/farmacologia , Schistosoma mansoni/efeitos dos fármacos , Administração Oral , Animais , Anti-Helmínticos/síntese química , Anti-Helmínticos/farmacologia , Anti-Helmínticos/uso terapêutico , Apirase/antagonistas & inibidores , Apirase/metabolismo , Sítios de Ligação , Chalconas/síntese química , Chalconas/química , Chalconas/uso terapêutico , Modelos Animais de Doenças , Proteínas de Helminto/antagonistas & inibidores , Proteínas de Helminto/metabolismo , Camundongos , Microscopia Confocal , Microscopia Eletrônica de Varredura , Simulação de Acoplamento Molecular , Estrutura Terciária de Proteína , Schistosoma mansoni/enzimologia , Esquistossomose mansoni/tratamento farmacológico , Esquistossomose mansoni/patologia , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...